Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:33 PM
Ignite Modification Date:
2025-12-24 @ 5:33 PM
NCT ID:
NCT00211068
Eligibility Criteria:
Inclusion Criteria:
* History of anemia due to chronic kidney disease
* Pure red cell aplasia (PRCA) associated with erythropoietin-alpha (EPO) treatment
* Treatment with EPO for a minimum of 2 months occurring within more or less 3 months of the reference date (date of loss of efficacy \[drop in hemoglobin of greater than 2 g/dL/month\] was first observed)
Exclusion criteria
* History of and information related to past exposure to EPO not available
* History of PRCA or anti-EPO antibody positive status before or after the reference date
Healthy Volunteers:
False
Sex:
ALL
Study:
NCT00211068
Study Brief:
Protocol Section:
NCT00211068